Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
This article simplifies altcoins that beginners find approachable, outlining key features, how they differ from BTC, and practical steps to research safely.
20,932 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
SoFi is pursuing growth beyond lending with AI-powered tools. This article explores whether AI agents could be the ne...
Investors rewarded Meta Platforms after news suggesting a sharper AI-driven monetization strategy and resilient ad de...
A $28 billion AI hardware IPO is trading at about 7x forward earnings, sparking a heated debate: is it a disrupted, d...
Tesla could redefine AI profitability by owning the stack from hardware to the finished product. A new investment the...
As the market wrestles with SaaS cycles and AI disruption fears, monday.com stock has seen its share of monday blues....
Investors are tilting toward Argentina’s reform story via a single-country ETF, while broad Latin America funds like ...
Mega-cap AI bets are fueling a surge in debt issuance this year, prompting fresh debate over whether the AI expansion...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
GE Vernova arrives at its July 22 earnings with a $163 billion backlog and raised targets, signaling a strong beat ri...
Retirees often seek steady income with minimal fuss. These magnificent ETFs retirees that pay above 3% can fit a simp...
The United States still holds a 714-million-barrel strategic reserve capacity, a focal point for policy debates and e...